Daniel B.

Daniel B. is currently the Head of Medical Affairs & Evidence Generation Strategy and Planning at argenx, where they lead strategic and operational planning for the Medical Affairs and Evidence Generation organization. Previously, they held significant leadership roles at Bristol-Myers Squibb, GSK, and Takeda, managing large-scale budgets and driving operational efficiencies in various departments. Daniel earned an MBA in Marketing from Rutgers University and holds a B.S. in Exercise Science from The College of New Jersey, as well as an Associate of Science in Biology from Mercer County Community College.